Pharmaceuticals, Biotechnology and Life Sciences
Prescription Drug User Fee Act (PDUFA) goal date extended by three months for further review of submission to September 25,…
Large Phase 2 efficacy trial cleared to start in the United Kingdom in newly diagnosed SARS-CoV-2 infected patients.COVI-DROPS is administered…
Listing Transition to Proceed as Previously Announced to Maintain Regulatory Compliance as a U.S.-Based, Plant-Touching Cannabis Company Following Business Combination…
BELTSVILLE, Md., June 10, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and…
Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting NRP2. aNRP2-14 blocks Semaphorin 3F/NRP2…
CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today that it will hold an Investor…
Submitted first premarket approval (PMA) application in the Company’s history to FDA for LungFit® PH to treat persistent pulmonary hypertension…
– Webinar on Monday, June 21, 2021 at 11:00 a.m. ET – MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) — Theratechnologies…
VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) — Segra International Corp, a leading cannabis agriculture technology company, is pleased…
SUWON, Republic of Korea, June 10, 2021 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi…